OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prevention of Fibrosis and Pathological Cardiac Remodeling by Salinomycin
Ryan M. Burke, Ronald Dirkx, Pearl Quijada, et al.
Circulation Research (2021) Vol. 128, Iss. 11, pp. 1663-1678
Open Access | Times Cited: 24

Showing 24 citing articles:

Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention
Xiaoying Yin, Xinxin Yin, Xin Pan, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 33

Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target
Hao Zhang, Phung N. Thai, Rabindra V. Shivnaraine, et al.
Cell (2024)
Closed Access | Times Cited: 11

Brown Adipocyte ADRB3 Mediates Cardioprotection via Suppressing Exosomal iNOS
Jing-Rong Lin, Liliqiang Ding, Lian Xu, et al.
Circulation Research (2022) Vol. 131, Iss. 2, pp. 133-147
Closed Access | Times Cited: 32

Fibroblasts orchestrate cellular crosstalk in the heart through the ECM
Stephanie Bowers, Qinghang Meng, Jeffery D. Molkentin
Nature Cardiovascular Research (2022) Vol. 1, Iss. 4, pp. 312-321
Closed Access | Times Cited: 26

Fibroblasts and immune cells: at the crossroad of organ inflammation and fibrosis
Sasha Smolgovsky, Brandon Theall, Noah Wagner, et al.
AJP Heart and Circulatory Physiology (2023) Vol. 326, Iss. 2, pp. H303-H316
Closed Access | Times Cited: 14

Hitting the Target! Challenges and Opportunities for TGF-β Inhibition for the Treatment of Cardiac fibrosis
Maria Vistnes
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 267-267
Open Access | Times Cited: 5

Roles of Epigenetics in Cardiac Fibroblast Activation and Fibrosis
Jingrong Shao, Jiao Liu, Shengkai Zuo
Cells (2022) Vol. 11, Iss. 15, pp. 2347-2347
Open Access | Times Cited: 20

Inhibition of Eicosanoid Degradation Mitigates Fibrosis of the Heart
Marcello Rubino, Joshua G. Travers, Alaina L. Headrick, et al.
Circulation Research (2022) Vol. 132, Iss. 1, pp. 10-29
Open Access | Times Cited: 15

The NLRP3 Inflammasome: Relevance in Solid Organ Transplantation
Ryan M. Burke, Bethany L. Dale, Shamik Dholakia
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10721-10721
Open Access | Times Cited: 16

The role of serine/threonine protein kinases in cardiovascular disease and potential therapeutic methods
Yanjiao Wu, Yuanming Zou, Chunyu Song, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117093-117093
Open Access | Times Cited: 2

Salinomycin, a potent inhibitor of XOD and URAT1, ameliorates hyperuricemic nephropathy by activating NRF2, modulating the gut microbiota, and promoting SCFA production
Yongjun Chen, Zitao Guo, Hai-Qiao Chen, et al.
Chemico-Biological Interactions (2024) Vol. 403, pp. 111220-111220
Closed Access | Times Cited: 2

Polyether Ionophore Antibiotics Target Drug-Resistant Clinical Isolates, Persister Cells, and Biofilms
Malene Wollesen, Kasper Mikkelsen, Marie Selch Tvilum, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 5

The Macrophage–Fibroblast Dipole in the Context of Cardiac Repair and Fibrosis
Stelios Psarras
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1403-1403
Open Access | Times Cited: 1

Transcriptional regulation of cardiac fibroblast phenotypic plasticity
Kimberly N. Burgos Villar, Xiaoyi Liu, Eric M. Small
Current Opinion in Physiology (2022) Vol. 28, pp. 100556-100556
Open Access | Times Cited: 7

Cardiac Fibroblast-Specific Knockout of PGC-1α Accelerates AngII-Induced Cardiac Remodeling
Hongjin Chen, Xiaoxi Pan, Liliqiang Ding, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 7

Oleanolic acid derivative alleviates cardiac fibrosis through inhibiting PTP1B activity and regulating AMPK/TGF-β/Smads pathway
Anhui Wang, Haoyue Ma, Yan-Liang Yi, et al.
European Journal of Pharmacology (2023) Vol. 960, pp. 176116-176116
Closed Access | Times Cited: 2

Transcriptional plasticity of fibroblasts in heart disease
Rudi Micheletti, Michael Alexanian
Biochemical Society Transactions (2022) Vol. 50, Iss. 5, pp. 1247-1255
Open Access | Times Cited: 3

New Opportunities in Heart Failure with Preserved Ejection Fraction: From Bench to Bedside… and Back
Alfredo Parra-Lucares, Esteban Romero-Hernández, Eduardo Villa, et al.
Biomedicines (2022) Vol. 11, Iss. 1, pp. 70-70
Open Access | Times Cited: 3

Short-Chain Acyl-CoA Dehydrogenase as a Therapeutic Target for Cardiac Fibrosis
Zhaohui Shu, Jingyun Feng, Lanting Liu, et al.
Journal of Cardiovascular Pharmacology (2024) Vol. 83, Iss. 5, pp. 410-432
Closed Access

Salinomycin attenuates kidney fibrosis and inflammation in mice with unilateral ureteral obstruction
Kuan‐Hsing Chen, Hsiang‐Hao Hsu, Huang‐Yu Yang, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 742, pp. 151130-151130
Closed Access

Cell-Based Phenotypic Screen for Antifibrotic Compounds Targets Eicosanoid Metabolism
Janet K. Lighthouse, Eric M. Small
Circulation Research (2023) Vol. 132, Iss. 1, pp. 30-33
Closed Access

Polyether ionophore antibiotics target drug-resistant clinical isolates, persister cells, and biofilms
Malene Wollesen, Kasper Mikkelsen, Marie Selch Tvilum, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Page 1

Scroll to top